Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Michael Parsons, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Medical College of Wisconsin, Milwaukee, WI08/1999Neuropsychology Residency
University of Texas, Austin, Austin, TX, USAPhD08/1997Clinical Psychology
University of Florida, Gainesville, FL, USA07/1996Clinical Psychology Internship
University of Virginia, Charlottesville, VA, USABA05/1989Psychology, Biology

Overview
Michael W. Parsons, PhD, ABPP is a clinical neuropsychologist in the Pappas Neuro-Oncology Center and Department of Psychiatry at Massachusetts General Hospital. His clinical and research activities focus on the cognitive and behavioral consequences of cancer, including both brain tumors and non-central nervous system cancers. He provides neuropsychological evaluations for adults with cancer, addressing the cognitive issues that are caused by cancer and its treatment. His research involves the use of cognitive assessments and advanced brain imaging techniques to understand how cancer affects neural systems and the efficacy of treatment for these problems. He is the author of numerous peer reviewed manuscripts and book chapters related to these issues and serves as the co-president of the Neuro-oncology special interest group of the International Neuropsychological Society. Dr. Parsons is a Diplomate of the American Board of Clinical Neuropsychology and the American Board of Professional Psychology.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022 Jun 28. PMID: 35762249.
    Citations:    Fields:    
  2. Park DY, Tom MC, Chen Y, Tewari S, Ahluwalia MS, Yu JS, Chao ST, Suh JH, Peereboom DM, Stevens GHJ, Barnett GH, Angelov L, Mohammadi A, Hogan T, Kissel C, Lapin B, Schuermeyer I, Parsons MW, Naugle R, Murphy ES. Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas. J Neurooncol. 2022 Jul; 158(3):341-348. PMID: 35486307.
    Citations:    Fields:    Translation:Humans
  3. Forst DA, Podgurski AF, Quain KM, Landay SL, Anand M, Kaslow-Zieve E, Mesa MM, Jacobs JM, Dietrich J, Parsons MW, Horick N, Greer JA, Batchelor TT, Jackson VA, El-Jawahri A, Temel JS. Factors associated with psychological distress in caregivers of patients with malignant gliomas. Support Care Cancer. 2022 Jul; 30(7):5811-5820. PMID: 35353218.
    Citations: 1     Fields:    Translation:Humans
  4. Delahunty R, Nguyen L, Craig S, Creighton B, Ariyaratne D, Garsed DW, Christie E, Fereday S, Andrews L, Lewis A, Limb S, Pandey A, Hendley J, Traficante N, Carvajal N, Spurdle AB, Thompson B, Parsons MT, Beshay V, Volcheck M, Semple T, Lupat R, Doig K, Yu J, Chen XQ, Marsh A, Love C, Bilic S, Beilin M, Nichols CB, Greer C, Lee YC, Gerty S, Gill L, Newton E, Howard J, Williams R, Norris C, Stephens AN, Tutty E, Smyth C, O'Connell S, Jobling T, Stewart CJR, Tan A, Fox SB, Pachter N, Li J, Ellul J, Mir Arnau G, Young MA, Gordon L, Forrest L, Harris M, Livingstone K, Hill J, Chenevix-Trench G, Cohen PA, Webb PM, Friedlander M, James P, Bowtell D, Alsop K. TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members. J Clin Oncol. 2022 Jun 20; 40(18):2036-2047. PMID: 35263119; PMCID: PMC9197360.
    Citations:    Fields:    Translation:Humans
  5. Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, Buecher B, Buys SS, Caputo SM, Chung WK, Colas C, Colonna SV, Cook J, Daly MB, de la Hoya M, de Pauw A, Delhomelle H, Eason J, Engel C, Evans DG, Faust U, Fehm TN, Fostira F, Fountzilas G, Frone M, Garcia-Barberan V, Garre P, Gauthier-Villars M, Gehrig A, Glendon G, Goldgar DE, Golmard L, Greene MH, Hahnen E, Hamann U, Hanson H, Hassan T, Hentschel J, Horvath J, Izatt L, Janavicius R, Jiao Y, John EM, Karlan BY, Kim SW, Konstantopoulou I, Kwong A, Laugé A, Lee JW, Lesueur F, Mebirouk N, Meindl A, Mouret-Fourme E, Musgrave H, Ngeow Yuen Yie J, Niederacher D, Park SK, Pedersen IS, Ramser J, Ramus SJ, Rantala J, Rashid MU, Reichl F, Ritter J, Rump A, Santamariña M, Saule C, Schmidt G, Schmutzler RK, Senter L, Shariff S, Singer CF, Southey MC, Stoppa-Lyonnet D, Sutter C, Tan Y, Teo SH, Terry MB, Thomassen M, Tischkowitz M, Toland AE, Torres D, Vega A, Wagner SA, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Spurdle AB, Easton DF, Chenevix-Trench G, Ottini L, Antoniou AC. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J Clin Oncol. 2022 05 10; 40(14):1529-1541. PMID: 35077220; PMCID: PMC9084432.
    Citations: 5     Fields:    Translation:Humans
  6. Park DY, Tom MC, Wei W, Tewari S, Ahluwalia MS, Yu JS, Chao ST, Suh JH, Peereboom D, Stevens GHJ, Barnett GH, Angelov L, Mohammadi AM, Hogan T, Kissel C, Lapin B, Schuermeyer I, Parsons MW, Naugle R, Murphy ES. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma. J Neurooncol. 2022 Feb; 156(3):499-507. PMID: 35064450.
    Citations:    Fields:    Translation:Humans
  7. Giuliana V Zarrella, Alice Perez, Jorg Dietrich, Michael W Parsons. Reliability and validity of a novel cognitive self-assessment tool for patients with cancer. Neuro-Oncology Practice. 2021; 8(6):691–698. View Publication.
  8. Parsons MW, Peters KB, Floyd SR, Brown P, Wefel JS. Preservation of neurocognitive function in the treatment of brain metastases. Neurooncol Adv. 2021 Nov; 3(Suppl 5):v96-v107. PMID: 34859237; PMCID: PMC8633744.
    Citations: 1     
  9. Pulsifer MB, Grieco JA, Burstein SM, Parsons MW, Gardner MM, Sherman JC. The development and implementation of teleneuropsychology in an academic lifespan neuropsychology center: Lessons learned from the COVID-19 pandemic. J Clin Exp Neuropsychol. 2021 10; 43(8):774-785. PMID: 34384335.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  10. Brown PD, Parsons MW, Rusthoven CG, Gondi V. Hippocampal Avoidance Prophylactic Cranial Irradiation: A New Standard of Care? J Clin Oncol. 2021 10 01; 39(28):3093-3096. PMID: 34379456.
    Citations:    Fields:    Translation:Humans
  11. Zarrella GV, Perez A, Dietrich J, Parsons MW. Reliability and validity of a novel cognitive self-assessment tool for patients with cancer. Neurooncol Pract. 2021 Dec; 8(6):691-698. PMID: 34777838; PMCID: PMC8579089.
    Citations: 1     
  12. Kontos N, Parsons MW, Biffi A, González RG. Case 19-2021: A 54-Year-Old Man with Irritability, Confusion, and Odd Behaviors. N Engl J Med. 2021 Jun 24; 384(25):2438-2445. PMID: 34161710.
    Citations:    Fields:    Translation:Humans
  13. Parsons MW, Dietrich J. Assessment and Management of Cognitive Symptoms in Patients With Brain Tumors. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e90-e99. PMID: 34061562.
    Citations:    Fields:    Translation:Humans
  14. Parsons MW, Gardner MM, Sherman JC, Pasquariello K, Grieco JA, Kay CD, Pollak LE, Morgan AK, Carlson-Emerton B, Seligsohn K, Davidsdottir S, Pulsifer MB, Zarrella GV, Burstein SM, Mancuso SM. Feasibility and Acceptance of Direct-to-Home Tele-neuropsychology Services during the COVID-19 Pandemic. J Int Neuropsychol Soc. 2022 02; 28(2):210-215. PMID: 33952375.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  15. Gardner MM, Aslanzadeh FJ, Zarrella GV, Braun SE, Loughan AR, Parsons MW. Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients. Neurooncol Pract. 2021 Aug; 8(4):485-496. PMID: 34267923; PMCID: PMC8083492.
    Citations: 1     
  16. Forst DA, Quain K, Landay SL, Anand M, Kaslow-Zieve E, Mesa MM, Jacobs JM, Dietrich J, Parsons MW, Horick N, Greer JA, Batchelor TT, Jackson VA, El-Jawahri A, Temel JS. Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregivers. Neurooncol Pract. 2020 Oct; 7(5):490-497. PMID: 33014389; PMCID: PMC7516113.
    Citations: 5     
  17. Noll KR, Bradshaw ME, Parsons MW, Dawson EL, Rexer J, Wefel JS. Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors. Curr Treat Options Neurol. 2019 Jun 28; 21(7):33. PMID: 31250277.
    Citations: 7     
  18. Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS. Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal? Am Soc Clin Oncol Educ Book. 2019 Jan; 39:133-145. PMID: 31099638.
    Citations: 24     Fields:    Translation:Humans
  19. Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol. 2019 02; 20(2):e92-e102. PMID: 30723041.
    Citations: 18     Fields:    Translation:Humans
  20. Parsons MW, Dietrich J. Assessment and management of cognitive changes in patients with cancer. Cancer. 2019 06 15; 125(12):1958-1962. PMID: 30668896.
    Citations:    Fields:    Translation:Humans
  21. Busch RM, Hogue O, Ferguson L, Parsons MW, Kubu CS, Floden DP. Validation of computerized episodic memory measures in a diverse clinical sample referred for neuropsychological assessment. Clin Neuropsychol. 2019 04; 33(3):557-570. PMID: 29996710; PMCID: PMC6333509.
    Citations: 1     Fields:    Translation:Humans
  22. Wefel JS, Parsons MW, Gondi V, Brown PD. Neurocognitive aspects of brain metastasis. Handb Clin Neurol. 2018; 149:155-165. PMID: 29307352.
    Citations: 8     Fields:    Translation:Humans
  23. Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, Kotecha R, Jia X, Peereboom DM, Prayson RA, Stevens GHJ, Barnett GH, Vogelbaum MA, Ahluwalia MS. Risk Factors for Malignant Transformation of Low-Grade Glioma. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):965-971. PMID: 29485076.
    Citations: 30     Fields:    Translation:Humans
  24. Kotecha R, Vogel S, Suh JH, Barnett GH, Murphy ES, Reddy CA, Parsons M, Vogelbaum MA, Angelov L, Mohammadi AM, Stevens GHJ, Peereboom DM, Ahluwalia MS, Chao ST. A cure is possible: a study of 10-year survivors of brain metastases. J Neurooncol. 2016 09; 129(3):545-555. PMID: 27456950.
    Citations: 11     Fields:    Translation:Humans
  25. Ahluwalia MS, Chao ST, Parsons MW, Suh JH, Wang D, Mikkelsen T, Brewer CJ, Smolenski KN, Schilero C, Rump M, Elson P, Angelov L, Barnett GH, Vogelbaum MA, Weil RJ, Peereboom DM. Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases. J Neurooncol. 2015 Sep; 124(3):485-91. PMID: 26245136.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  26. Newsome MR, Durgerian S, Mourany L, Scheibel RS, Lowe MJ, Beall EB, Koenig KA, Parsons M, Troyanskaya M, Reece C, Wilde E, Fischer BL, Jones SE, Agarwal R, Levin HS, Rao SM. Disruption of caudate working memory activation in chronic blast-related traumatic brain injury. Neuroimage Clin. 2015; 8:543-53. PMID: 26110112.
    Citations: 12     Fields:    Translation:Humans
  27. Moore HC, Parsons MW, Yue GH, Rybicki LA, Siemionow W. Electroencephalogram power changes as a correlate of chemotherapy-associated fatigue and cognitive dysfunction. Support Care Cancer. 2014 Aug; 22(8):2127-31. PMID: 24647490.
    Citations: 7     Fields:    Translation:Humans
  28. Fischer BL, Parsons M, Durgerian S, Reece C, Mourany L, Lowe MJ, Beall EB, Koenig KA, Jones SE, Newsome MR, Scheibel RS, Wilde EA, Troyanskaya M, Merkley TL, Walker M, Levin HS, Rao SM. Neural activation during response inhibition differentiates blast from mechanical causes of mild to moderate traumatic brain injury. J Neurotrauma. 2014 Jan 15; 31(2):169-79. PMID: 24020449.
    Citations: 33     Fields:    Translation:Humans
  29. Brefczynski-Lewis J, Lowitszch S, Parsons M, Lemieux S, Puce A. Audiovisual non-verbal dynamic faces elicit converging fMRI and ERP responses. Brain Topogr. 2009 May; 21(3-4):193-206. PMID: 19384602.
    Citations: 9     Fields:    Translation:Humans
  30. Boling W, Parsons M, Kraszpulski M, Cantrell C, Puce A. Whole-hand sensorimotor area: cortical stimulation localization and correlation with functional magnetic resonance imaging. J Neurosurg. 2008 Mar; 108(3):491-500. PMID: 18312096.
    Citations: 4     Fields:    Translation:Humans
  31. Haut MW, Kuwabara H, Ducatman AM, Hatfield G, Parsons MW, Scott A, Parsons E, Morrow LA. Corpus callosum volume in railroad workers with chronic exposure to solvents. J Occup Environ Med. 2006 Jun; 48(6):615-24. PMID: 16766926.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  32. Parsons MW, Haut MW, Lemieux SK, Moran MT, Leach SG. Anterior medial temporal lobe activation during encoding of words: FMRI methods to optimize sensitivity. Brain Cogn. 2006 Apr; 60(3):253-61. PMID: 16472901.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  33. Parsons MW, Harrington DL, Rao SM. Distinct neural systems underlie learning visuomotor and spatial representations of motor skills. Hum Brain Mapp. 2005 Mar; 24(3):229-47. PMID: 15543554.
    Citations: 13     Fields:    Translation:Humans
  34. Stone WS, Rudd RJ, Parsons MW, Gold PE. Memory scores in middle-aged rats predict later deficits in memory, paradoxical sleep, and blood glucose regulation in old age. Exp Aging Res. 1997 Jul-Sep; 23(3):287-300. PMID: 9248821.
    Citations: 7     Fields:    Translation:Animals
  35. Manning CA, Parsons MW, Gold PE. Anterograde and retrograde enhancement of 24-h memory by glucose in elderly humans. Behav Neural Biol. 1992 Sep; 58(2):125-30. PMID: 1456931.
    Citations: 11     Fields:    Translation:Humans
  36. Parsons MW, Gold PE. Glucose enhancement of memory in elderly humans: an inverted-U dose-response curve. Neurobiol Aging. 1992 May-Jun; 13(3):401-4. PMID: 1625769.
    Citations: 23     Fields:    Translation:Humans
  37. Parsons MW, Gold PE. Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose. Behav Neural Biol. 1992 Jan; 57(1):90-2. PMID: 1567337.
    Citations: 2     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Parsons's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (160)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.